Men diagnosed at this hospital trust can access the following services:

• Diagnostic Facilities:
• Multiparametric MRI
• Transperineal biopsy under local anaesthetic
• Transperineal biopsy under general anaesthetic
• Transrectal ultrasound (TRUS) biopsy
• Choline PET
• PSMA (prostate-specific membrane antigen) PET scan
• Isotope bone scan

• Treatment Facilities:
• Radical prostatectomy
• External beam radiotherapy (EBRT)
• Chemotherapy

• Support Service Facilities:
• Clinical Nurse Specialist (CNS) in all clinics
• Prostate cancer-specific CNSs
• Advanced PCa CNS
• Urology CNS
• Sexual function services
• Specialist continence services
• Psychological counselling
• Genetic counselling

	Diagnosing Trust	Specialist MDT
No. of Cancer Registry records	487	487
Performance Status recorded	100%	100%
PSA completed	83%	83%
Gleason Score completed	83%	83%
TNM completed	37%	37%
Risk group assigned	91%	91%

	Specialist MDT	National
No. of men with disease status determined	451	23477
Percentage of men diagnosed with metastatic disease	13%	17%
No. of men diagnosed with M1 (metastases)	60	N/A

	Specialist MDT	National
No. of men diagnosed with low-risk localised disease	5	N/A
Percentage of men with low-risk localised disease receiving radical treatment	0%	0%
No. of men diagnosed with locally advanced disease	161	N/A
Percentage of men diagnosed with locally advanced disease receiving radical treatment	73%	0%

	Treatment Centre
No. of men who received radical prostatectomy (2020-2021)	30
Adjusted percentage of men who had an emergency readmission within 90 days of radical prostatectomy (%)	9%
No. of men who received radical prostatectomy (2019)	46
Adjusted percentage of men experiencing at least one GU complication (%)	3%
No. of men who received radical radiotherapy (2019)	200
Adjusted percentage of men experiencing at least one GI complication (%)	8%